Larvol Delta - CNS-Pharmaceuticals-Receives-Approval-from-Ethics-Committee-and-Competent-Authority-in-Spain-for-Potentially-Pivotal-Study-of-Berubicin-for-the-Treatment-of-Glioblastoma-Multiforme-GBM

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-receives-approval-from-ethics-committee-and-competent-authority-in-spain-for-potentially-pivotal-study-of-berubicin-for-the-treatment-of-glioblastoma-multiforme-gbm-301535127.html

Apr 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next